NCT00362882View on ClinicalTrials.gov

Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
DRUG

docetaxel

Given IV

DRUG

bortezomib

Given IV

OTHER

laboratory biomarker analysis

correlative study

OTHER

immunoenzyme technique

correlative study

OTHER

immunohistochemistry staining method

correlative study

OTHER

pharmacological study

correlative study

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00362882 - Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter